Market Place
Sourcing Support
Amneal Launches FOCINVEZ™, the First Ready-to-Use Version of Fosaprepitant
09 Jul 2024 //
BUSINESSWIRE
Enforcement Report - Week of January 31, 2024
31 Jan 2024 //
FDA
Techdow USA and CTTQ Pharma Announce Collaboration Agreement
22 Aug 2023 //
BUSINESSWIRE
Praxgen`s Fosaprepitant Dimeglumine Receives Approval in US
07 Oct 2021 //
FDA
ASPIRO`s Generic Fosaprepitant Dimeglumine Receives Tentative Approval In US
29 Jul 2021 //
FDA
AChia Tai Tianqing Generic Fosaprepitant Dimeglumine Receives Approval in US
08 Mar 2021 //
FDA
Aurobindo Pharma`s Generic Fosaprepitant Dimeglumine Receives Approval In US
20 Jan 2021 //
FDA
Qilu`s Generic Fosaprepitant Dimeglumine Receives Approval In US
08 Sep 2020 //
FDA
Accord Hlthcare’s Generics Fluoxetine Hydrochloride Receives Approval In US
27 Aug 2020 //
FDA
Navinta`s Generic Fosaprepitant Dimeglumine Receives Approval In US
20 Aug 2020 //
FDA
Enforcement Report - Week of July 22, 2020
22 Jul 2020 //
FDA
Sandoz acquires US distribution rights to two key hospital injectable medicines
23 Mar 2020 //
PR NEWSWIRE
Fresenius Kabi Announces Availability of Fosaprepitant for Injection
13 Nov 2019 //
BUSINESSWIRE
Dr Reddys launches generic Emend in US market
11 Sep 2019 //
MONEYCONTROL
Lupin`s Generic Fosaprepitant Dimeglumine Receives Approval in US
10 Sep 2019 //
FDA
SunGen Pharma Receives Seventh ANDA Approval from US FDA
06 Sep 2019 //
GLOBENEWSWIRE
MSN labs to launch two new generics in USA
06 Sep 2019 //
THEPHARMALETTER
MSN Labs Generic Fosaprepitant Dimeglumine Receives Approval In US
06 Sep 2019 //
FDA
Teva Pharms` Generic Fosaprepitant Receives Approval in US
05 Sep 2019 //
FDA
Novadoz Pharma /MSN Labs Receives FDA Clearance for Fosaprepitant & Decitabine
05 Sep 2019 //
PR NEWSWIRE
Copycats wanted: Pfizer, AZ and more under threat as China solicits generics
21 Jun 2019 //
FIERCE PHARMA
Lupin`s Generic Fosaprepitant Dimeglumine Receives Tentative Approval in US
08 May 2019 //
FDA
Lupin receives US FDA tentative marketing approval for generic Emend for Inj
07 May 2019 //
PHARMABIZ
Heron Announces FDA Approval of sNDA to Expand CINVANTI® Label for IV Push
26 Feb 2019 //
PR NEWSWIRE
Six medicines recommended for approval, including one orphan
24 Mar 2018 //
EMA
Emend®(Fosaprepitant Dimeglumine): Merck Sharp & Dohme Corp. V. MSN Laboratories
16 Jan 2018 //
PATENT LITIGATION
Heron takes on Merck`s Emend with FDA win for antinausea drug Cinvanti
11 Nov 2017 //
FIERCE PHARMA
Glenmark gets US FDA nod for generic of Emend capsules
16 Oct 2017 //
INDIAINFOLINE
Facing off rivals, Merck looks to expand CINV label on positive PhIII Emend study
29 Jun 2015 //
FIERCE BIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.